Central obesity and altered peripheral adipose tissue gene expression characterize the NAFLD patient with insulin resistance: Role of nutrition and insulin challenge

Nutrition

Volumn 30, Issue 2, 2014, Pages 177-185

  Paniagua, J A ^a   Escandell Morales, J M ^a   Gil Contreras, D ^a   Berral de la Rosa, F J ^b   Romero Jimenez, M ^a   Gomez Urbano A ^a   Sanchez Lopez, A ^a   Bellido, E ^a   Poyato, A ^a   Calatayud, B ^a   Vidal Puig, A J ^c  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Adipokines and leptin; Adipose tissue dysfunction; Insulin resistance; Nonalcoholic fatty liver disease

Indexed keywords

CARBOHYDRATE; GLUCAGON RECEPTOR; INSULIN; LEPTIN; MESSENGER RNA; MONOUNSATURATED FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SATURATED FATTY ACID;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BODY COMPOSITION; CALORIMETRY; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENERGY BALANCE; FAT INTAKE; FEMALE; GCGR GENE; GENE EXPRESSION; GENE INDUCTION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEP GENE; LIPID STORAGE; MALE; MICROARRAY ANALYSIS; NONALCOHOLIC FATTY LIVER; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; POSTPRANDIAL STATE; PPARG GENE; PRIORITY JOURNAL; WHITE ADIPOSE TISSUE;

ADIPOKINES AND LEPTIN; ADIPOSE TISSUE DYSFUNCTION; INSULIN RESISTANCE; NONALCOHOLIC FATTY LIVER DISEASE;

ABSORPTIOMETRY, PHOTON; ADIPONECTIN; ADIPOSE TISSUE, WHITE; ADULT; BODY COMPOSITION; BODY MASS INDEX; CROSS-OVER STUDIES; DIETARY CARBOHYDRATES; ENERGY METABOLISM; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FATTY LIVER; FEMALE; FOOD HABITS; GENE EXPRESSION; HUMANS; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; LEPTIN; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY, ABDOMINAL; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84891104660     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.07.017     Document Type: Article

References (48)

1. Vanni E., Bugianesi E., Kotronen A., De Minicis S., Yki-Jarvinen H., Svegliati-Baroni G. From the metabolic syndrome to NAFLD or vice versaα. Dig Liver Dis 2010, 42:320-330.
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
3. Bonnet F., Ducluzeau P.H., Gastaldelli A., Laville M., Anderwald C.H., Konrad T., et al. Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. Diabetes 2011, 60:1660-1667.
4. Petta S., Macaluso F.S., Barcellona M.R., Camma C., Cabibi D., Di Marco V., et al. Serum gamma-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases. PloS ONE 2012, 7:e51165.
5. Sattar N., Scherbakova O., Ford I., O'Reilly D.S., Stanley A., Forrest E., et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes 2004, 53:2855-2860.
6. Targher G., Day C.P., Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010, 363:1341-1350.
7. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Bugianesi E., Lenzi M., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001, 50:1844-1850.
8. Dixon J.B., Bhathal P.S., O'Brien P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001, 121:91-100.
9. Fabbrini E., Sullivan S., Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010, 51:679-689.
10. Garcia-Monzon C., Martin-Perez E., Iacono O.L., Fernandez-Bermejo M., Majano P.L., Apolinario A., et al. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 2000, 33:716-724.
11. Shimabukuro M., Koyama K., Chen G., Wang M.Y., Trieu F., Lee Y., et al. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci U S A 1997, 94:4637-4641.
12. Muoio D.M., Dohm G.L., Fiedorek F.T., Tapscott E.B., Coleman R.A. Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 1997, 46:1360-1363.
13. Cohen P., Ntambi J.M., Friedman J.M. Stearoyl-CoA desaturase-1 and the metabolic syndrome. Curr Drug Targets Immune Endocr Metabol Disord 2003, 3:271-280.
14. Barzilai N., Wang J., Massilon D., Vuguin P., Hawkins M., Rossetti L. Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest 1997, 100:3105-3110.
15. Reitman M.L., Arioglu E., Gavrilova O., Taylor S.I. Lipoatrophy revisited. Trends Endocrinol Metab 2000, 11:410-416.
16. Paniagua J.A., de la Sacristana A.G., Sanchez E., Romero I., Vidal-Puig A., Berral F.J., et al. A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr 2007, 26:434-444.
17. McKeown N.M., Meigs J.B., Liu S., Saltzman E., Wilson P.W., Jacques P.F. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care 2004, 27:538-546.
18. Abid A., Taha O., Nseir W., Farah R., Grosovski M., Assy N. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 2009, 51:918-924.
19. Paniagua J.A., Gallego de la Sacristana A., Romero I., Vidal-Puig A., Latre J.M., Sanchez E., et al. Monounsaturated fat-rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects. Diabetes Care 2007, 30:1717-1723.
20. Catta-Preta M., Martins M.A., Cunha Brunini T.M., Mendes-Ribeiro A.C., Mandarim-de-Lacerda C.A., et al. Modulation of cytokines, resistin, and distribution of adipose tissue in C57BL/6 mice by different high-fat diets. Nutrition 2012, 28:212-219.
21. Saverymuttu S.H., Joseph A.E., Maxwell J.D. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 1986, 292:13-15.
22. Giovannucci E., Colditz G., Stampfer M.J., Rimm E.B., Litin L., Sampson L., Willett W.C. The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol 1991, 133:810-817.
23. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
24. Martin-Moreno J.M., Boyle P., Gorgojo L., Maisonneuve P., Fernandez-Rodriguez J.C., Salvini S., et al. Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol 1993, 22:512-519.
25. Fernandez-Ballart J.D., Pinol J.L., Zazpe I., Corella D., Carrasco P., Toledo E., et al. Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br J Nutr 2010, 103:1808-1816.
26. Ainsworth B.E., Haskell W.L., Whitt M.C., Irwin M.L., Swartz A.M., Strath S.J., et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000, 32:S498-S504.
27. Lukaski H.C., Bolonchuk W.W., Hall C.B., Siders W.A. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 1986, 60:1327-1332.
28. Weir J.B. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949, 109:1-9.
29. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3. RESEARCH0034.
30. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45.
31. Marchesini G., Marzocchi R., Agostini F., Bugianesi E. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol 2005, 16:421-427.
32. Zhang Y., Lu X., Hong J., Chao M., Gu W., Wang W., Ning G. Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus. Endocrine 2010, 38:181-187.
33. Musso G., Gambino R., Pacini G., De Michieli F., Cassader M. Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver. Am J Clin Nutr 2009, 89:558-567.
34. Estadella D., da Penha Oller do Nascimento C.M., Oyama L.M., Ribeiro E.B., Damaso A.R., de Piano A. Lipotoxicity: effects of dietary saturated and transfatty acids. Mediators Inflamm 2013, 2013:137579.
35. Vessby B., Uusitupa M., Hermansen K., Riccardi G., Rivellese A.A., Tapsell L.C., et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 2001, 44:312-319.
36. Uyeda K., Repa J.J. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell metabolism 2006, 4:107-110.
37. Valtuena S., Pellegrini N., Ardigo D., Del Rio D., Numeroso F., Scazzina F., et al. Dietary glycemic index and liver steatosis. Am J Clin Nutr 2006, 84:136-142. quiz 268-9.
38. Polyzos S.A., Toulis K.A., Goulis D.G., Zavos C., Kountouras J. Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Metabolism 2011, 60:313-326.
39. Baranova A., Gowder S.J., Schlauch K., Elariny H., Collantes R., Afendy A., et al. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance. Obesity Surgery 2006, 16:1118-1125.
40. Bonhomme S., Guijarro A., Keslacy S., Goncalves C.G., Suzuki S., Chen C., et al. Gastric bypass up-regulates insulin signaling pathway. Nutrition 2011, 27:73-80.
41. Javor E.D., Cochran E.K., Musso C., Young J.R., Depaoli A.M., Gorden P. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. Diabetes 2005, 54:1994-2002.
42. Javor E.D., Ghany M.G., Cochran E.K., Oral E.A., DePaoli A.M., Premkumar A., et al. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy. Hepatology 2005, 41:753-760.
43. Reseland J.E., Anderssen S.A., Solvoll K., Hjermann I., Urdal P., Holme I., et al. Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr 2001, 73:240-245.
44. Reseland J.E., Haugen F., Hollung K., Solvoll K., Halvorsen B., Brude I.R., et al. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 2001, 42:743-750.
45. Karbowska J., Kochan Z. Intermittent fasting up-regulates Fsp27/Cidec gene expression in white adipose tissue. Nutrition 2012, 28:294-299.
46. Belfort R., Harrison S.A., Brown K., Darland C., Finch J., Hardies J., et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 2006, 355:2297-2307.
47. Mantzoros C.S. Leptin in relation to the lipodystrophy-associated metabolic syndrome. Diabetes Metab J 2012, 36:181-189.
48. Moon H.S., Matarese G., Brennan A.M., Chamberland J.P., Liu X., Fiorenza C.G., et al. Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance. Diabetes 2011, 60:1647-1656.